What is the diagnostic work‑up for primary testicular failure, including measurement of follicle‑stimulating hormone (FSH), luteinizing hormone (LH), total testosterone, semen analysis, and testicular volume?

Diagnostic Work-Up for Primary Testicular Failure

In primary testicular failure, measure serum FSH, LH, and total testosterone in all patients, perform semen analysis with centrifugation to confirm azoospermia or severe oligozoospermia, assess testicular volume by orchidometry, and obtain karyotype analysis plus Y-chromosome microdeletion testing when sperm concentration is ≤5 million/mL or azoospermia is present. 1

Hormonal Assessment

Core Hormone Panel

• Measure FSH, LH, and testosterone in every man with suspected primary testicular failure, particularly when sperm concentration is abnormally low, sexual dysfunction is present, or clinical findings suggest endocrinopathy 1, 2.
• FSH >7.6 IU/L combined with testicular atrophy strongly indicates non-obstructive azoospermia and primary testicular failure, distinguishing it from obstructive causes where FSH remains <7.6 IU/L with normal testicular size 1.
• Elevated FSH reflects testicular stress with compensatory pituitary stimulation, indicating early testicular dysfunction that may precede measurable declines in sperm production 3.
• Low testosterone with elevated LH and FSH confirms hypergonadotropic hypogonadism characteristic of primary testicular failure 4, 5.

Hormone Interpretation Pitfalls

• The conventional FSH reference range of 1–12.4 IU/L is too broad for fertility assessment; use the more restrictive threshold of 7.6 IU/L for clinical decision-making 3, 1.
• Normal FSH does not exclude non-obstructive azoospermia—men with maturation arrest can have normal FSH levels despite absent spermatogenesis 1.
• A complete hormone profile (FSH, LH, testosterone together) provides more diagnostic information than FSH alone 5.

Semen Analysis

Proper Collection and Analysis

• Perform at least two semen analyses spaced one month apart when initial parameters are abnormal 1.
• Always centrifuge the ejaculate, suspend the pellet in a small volume, and examine microscopically to exclude rare sperm that would change the diagnosis from azoospermia to severe oligozoospermia 1.
• A single normal semen analysis cannot reliably differentiate fertile from infertile men, especially when FSH is elevated 3.

Semen Volume and pH

• Semen volume <1.4 mL combined with acidic pH <7.0 and azoospermia indicates distal genital-tract obstruction (e.g., congenital bilateral absence of vas deferens), not primary testicular failure 1.
• Normal semen pH effectively excludes complete distal obstruction 1.

Testicular Volume Measurement

Assessment Technique and Interpretation

• Measure testicular volume by orchidometry at the initial physical examination—it directly correlates with semen parameters and provides rapid fertility assessment 6.
• Testicular atrophy is the hallmark physical finding of primary testicular failure and helps differentiate it from obstructive causes where testes remain normal-sized 1.
• Testicular volume <30 mL correlates with abnormal sperm density and elevated FSH; volumes <20 mL associate with severe oligozoospermia, and <10 mL with azoospermia 6.
• Testicular volume shows the strongest negative correlation with serum FSH, followed by LH 6.
• Larger baseline testicular volume predicts better outcomes with fertility treatments and successful sperm retrieval 7, 8, 9.

Mandatory Genetic Testing

Indications for Genetic Evaluation

• Perform karyotype analysis and Y-chromosome microdeletion testing in all men with primary infertility and azoospermia or sperm concentration ≤5 million/mL 1.
• Approximately 4% of men with sperm concentration <5 million/mL have karyotype abnormalities 1.

Specific Genetic Abnormalities

• Klinefelter syndrome (47,XXY) is the most common sex-chromosome abnormality in this population 1.
• More severe aneuploidies (48,XXXY or 49,XXXXY) can also occur 1.
• Complete deletions of AZFa, AZFb, or AZFb/c (each occurring in ~1–2% of non-obstructive azoospermia) result in inability to retrieve sperm by testicular sperm extraction 1.
• AZFc deletions (65–70% of Y-microdeletions) may still allow successful sperm retrieval 1.
• CFTR mutation analysis is recommended when low semen volume, acidic pH, and azoospermia suggest congenital bilateral absence of vas deferens 1.

Diagnostic Algorithm

Primary Testicular Failure Phenotype

• Testicular atrophy + FSH >7.6 IU/L + elevated LH + low testosterone + azoospermia or severe oligozoospermia (≤5 million/mL) 1, 5.
• Presence of genetic abnormalities (karyotype anomalies or Y-microdeletions) further confirms the diagnosis 1.

Distinguishing from Obstructive Azoospermia

• Obstructive azoospermia shows normal testicular size, FSH <7.6 IU/L, normal testosterone, and dilated/firm epididymides or absent vas deferens 1.
• This contrasts sharply with the testicular atrophy and elevated gonadotropins of primary testicular failure 1.

Critical Clinical Pitfalls

• Never omit centrifugation of the ejaculate—rare sperm may be present and fundamentally alter management from azoospermia to severe oligozoospermia 1.
• Do not rely on normal FSH to exclude primary testicular failure; maturation arrest can present with normal FSH despite absent spermatogenesis 1.
• Genetic testing is mandatory before proceeding to testicular sperm extraction or ICSI, as detection of chromosomal translocations or Y-chromosome deletions influences therapeutic strategy and prognosis 1.
• Low semen volume must be evaluated together with pH; the combination of low volume and acidic pH strongly indicates distal obstruction rather than primary testicular failure 1.
• Men with lower testicular volume and karyotype abnormalities are at higher risk of developing testosterone deficiency after surgical sperm retrieval 8.